SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-043960
Filing Date
2021-08-12
Accepted
2021-08-12 16:05:49
Documents
4
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20210812.htm 8-K 30452
2 EX-99.1 achv-ex991_6.htm EX-99.1 296937
3 GRAPHIC grvswz1lulgu000003.jpg GRAPHIC 11441
4 GRAPHIC grvswz1lulgu000001.jpg GRAPHIC 18627
  Complete submission text file 0001564590-21-043960.txt   370370
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 211167489
SIC: 2835 In Vitro & In Vivo Diagnostic Substances